Български
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
nicotinic acid/затлъстяване
Линкът е запазен в клипборда
Страница 1 от 100 резултата
Mixed Effects Modeling Using Stochastic Differential Equations: Illustrated by Pharmacokinetic Data of Nicotinic Acid in Obese Zucker Rats.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Inclusion of stochastic differential equations in mixed effects models provides means to quantify and distinguish three sources of variability in data. In addition to the two commonly encountered sources, measurement error and interindividual variability, we also consider uncertainty in the
Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
This study investigates the impact of disease on nicotinic acid (NiAc)-induced changes in plasma concentrations of non-esterified fatty acids (NEFA). NiAc was given by constant intravenous infusion to normal Sprague-Dawley and obese Zucker rats, and arterial blood samples were taken for analysis of
Joint feedback analysis modeling of nonesterified fatty acids in obese Zucker rats and normal Sprague-Dawley rats after different routes of administration of nicotinic acid.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Data were pooled from several studies on nicotinic acid (NiAc) intervention of fatty acid turnover in normal Sprague-Dawley and obese Zucker rats in order to perform a joint PKPD of data from more than 100 normal Sprague-Dawley and obese Zucker rats, exposed to several administration routes and
Nicotinic Acid Accelerates HDL Cholesteryl Ester Turnover in Obese Insulin-Resistant Dogs.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
OBJECTIVE
Nicotinic acid (NA) treatment decreases plasma triglycerides and increases HDL cholesterol, but the mechanisms involved in these change are not fully understood. A reduction in cholesteryl ester transfer protein (CETP) activity has been advanced to explain most lipid-modulating effects of
Nicotinic acid decreases apolipoprotein B100-containing lipoprotein levels by reducing hepatic very low density lipoprotein secretion through a possible diacylglycerol acyltransferase 2 inhibition in obese dogs.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Apolipoprotein B100 (apoB100) is an essential component of very low density lipoprotein (VLDL) and low-density lipoprotein (LDL), both independent markers of cardiovascular risk. Nicotinic acid (NA) is an efficacious drug for decreasing VLDL and LDL, but the underlying mechanisms are unclear. For
Nicotinic acid timed to feeding reverses tissue lipid accumulation and improves glucose control in obese Zucker rats[S].
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Nicotinic acid (NiAc) is a potent inhibitor of lipolysis, acutely reducing plasma free fatty acid (FFA) concentrations. However, a major FFA rebound is seen during rapid NiAc washout, and sustained exposure is associated with tolerance development, with FFAs returning to pretreatment levels. Our aim
[Effect of nicotinic acid and adrenaline on plasmatic concentration of NEFA and blood sugar in obese children].
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
[Effects of nicotinic acid on the secretion of HGH in normal and obese subjects].
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
[Effect of nicotinic acid on metabolic phenomena caused by anaerobic work in obese subjects].
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Metabolic changes induced by a nicotinic acid derivative in patients with obesity grades 1, 2 and 3.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Effect of nicotinic acid administaation on plasma HGH, FFA and glucose in obese subjects and in hypopituitary patients.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Anti-diabetic effect of trigonelline and nicotinic acid, on KK-A(y) mice.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Trigonelline (TRG) and nicotinic acid (NA), in which the former but not the latter improved the blood glucose level in the oral glucose tolerance test (OGTT) in Goto-Kakizaki (GK) rats were tested for anti-diabetic effects in mellitus models of KK-A(y) obese mice that had type 2 diabetes. Blood
[Innovative therapies in metabolic diseases: ezetimibe (Ezétrol), nicotinic acid (Niaspan), acids omega-3 (Omacor), rimonabant (Acomplia)].
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
In the field of dyslipidemia and metabolic syndrome, four innovative therapies are reviewed: Ezetimibe (Ezétrol) is a selective cholesterol absorption inhibitor. Co-administration of ezetimibe with low dose of statins shows LDL lowering comparable to that of the highest dose of the respective statin
Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
NEFAs characteristically are elevated in obese NIDDM patients in both the basal state and after insulin. This elevation might aggravate glycemic control both by decreasing peripheral glucose disposal (glucose-fatty acid cycle), and by increasing HGO. Thus, lowering plasma NEFA levels might improve
Treatment with omega-3 fatty acid ethyl-ester alters fatty acid composition of lipoproteins in overweight or obese adults with insulin resistance.
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
BACKGROUND
The effects of dietary fatty acid supplementation on lipoprotein fatty acid composition have rarely been described.
METHODS
Sixty-one overweight and obese adults with dyslipidemia and insulin resistance were randomized to placebo, 2g/day extended-release nicotinic acid (ERN), 4g/day
Най-пълната база данни за лечебни билки, подкрепена от науката
- Работи на 55 езика
- Билкови лекове, подкрепени от науката
- Разпознаване на билки по изображение
- Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
- Прочетете научни публикации, свързани с вашето търсене
- Търсете лечебни билки по техните ефекти
- Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите
Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания
